These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37264061)

  • 41. Modulation of "Protective" Nicotine Perception and Use Profile by Flavorants: Preliminary Findings in E-cigarettes.
    DeVito EE; Jensen KP; O'Malley SS; Gueorguieva R; Krishnan-Sarin S; Valentine G; Jatlow PI; Sofuoglu M
    Nicotine Tob Res; 2020 Apr; 22(5):771-781. PubMed ID: 30995302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of Electronic Nicotine Delivery System Use With Cigarette Smoking Relapse Among Former Smokers in the United States.
    Everard CD; Silveira ML; Kimmel HL; Marshall D; Blanco C; Compton WM
    JAMA Netw Open; 2020 Jun; 3(6):e204813. PubMed ID: 32501492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patterns and Trends in Use of Electronic Nicotine Delivery Systems Before and During Pregnancy: Pregnancy Risk Assessment Monitoring System, United States, 2016-2019.
    Head SK; Zaganjor I; Kofie JN; Sawdey MD; Cullen KA
    J Community Health; 2022 Apr; 47(2):351-360. PubMed ID: 35022922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nicotine delivery to users from cigarettes and from different types of e-cigarettes.
    Hajek P; Przulj D; Phillips A; Anderson R; McRobbie H
    Psychopharmacology (Berl); 2017 Mar; 234(5):773-779. PubMed ID: 28070620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of menthol/mint-flavored pods on young JUUL E-cigarette users' subjective experience, puffing behavior, and nicotine exposure: A pilot study.
    Li W; Vargas-Rivera M; Eissenberg TE; Shihadeh A; Talih S; Maziak W
    Drug Alcohol Depend; 2022 Aug; 237():109516. PubMed ID: 35679691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Within-Person Longitudinal Associations Between Electronic Nicotine Delivery Systems Use and Smoking Cessation Efforts Among US Continuing Adult Cigarette Smokers.
    Han DH; Lee SH; Seo DC
    Nicotine Tob Res; 2022 Mar; 24(4):590-597. PubMed ID: 34758071
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nicotine concentrations with electronic cigarette use: effects of sex and flavor.
    Oncken CA; Litt MD; McLaughlin LD; Burki NA
    Nicotine Tob Res; 2015 Apr; 17(4):473-8. PubMed ID: 25762758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How Does the Use of Flavored Nicotine Vaping Products Relate to Progression Toward Quitting Smoking? Findings From the 2016 and 2018 ITC 4CV Surveys.
    Li L; Borland R; Cummings KM; Fong GT; Gravely S; Smith DM; Goniewicz ML; O'Connor RJ; Thompson ME; McNeill A
    Nicotine Tob Res; 2021 Aug; 23(9):1490-1497. PubMed ID: 33631007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. E-cigarette Nicotine Delivery: Data and Learnings from Pharmacokinetic Studies.
    Fearon IM; Eldridge A; Gale N; Shepperd CJ; McEwan M; Camacho OM; Nides M; McAdam K; Proctor CJ
    Am J Health Behav; 2017 Jan; 41(1):16-32. PubMed ID: 27935787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in Biomarkers of Tobacco Exposure among Cigarette Smokers Transitioning to ENDS Use: The Population Assessment of Tobacco and Health Study, 2013-2015.
    Anic GM; Rostron BL; Hammad HT; van Bemmel DM; Del Valle-Pinero AY; Christensen CH; Erives G; Faulcon LM; Blount BC; Wang Y; Wang L; Bhandari D; Calafat AM; Kimmel HL; Everard CD; Compton WM; Edwards KC; Goniewicz ML; Wei B; Hyland A; Hatsukami DK; Hecht SS; Niaura RS; Borek N; Ambrose BK; Chang CM
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristics and Patterns of Cigarette Smoking and Vaping By Past-Year Smokers Who Reported Using Electronic Nicotine Delivery System to Help Quit Smoking in the Past Year: Findings From the 2018-2019 Tobacco Use Supplement to the Current Population Survey.
    Chang JT; Mayer M; Jackson RA; Rostron BL; Coleman B; Lee T; Ambrose BK; Chang CM
    Nicotine Tob Res; 2023 Feb; 25(3):596-601. PubMed ID: 35973818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of FDA's Vuse market authorisation: limitations and opportunities.
    Meshnick AB; Faricy LE; Lushniak BD
    Tob Control; 2024 Mar; 33(e1):e116-e121. PubMed ID: 36764685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Responses to potential nicotine vaping product flavor restrictions among regular vapers using non-tobacco flavors: Findings from the 2020 ITC Smoking and Vaping Survey in Canada, England and the United States.
    Gravely S; Smith DM; Liber AC; Cummings KM; East KA; Hammond D; Hyland A; O'Connor RJ; Kasza KA; Quah ACK; Loewen R; Martin N; Meng G; Ouimet J; Thompson ME; Boudreau C; McNeill A; Sweanor DT; Fong GT
    Addict Behav; 2022 Feb; 125():107152. PubMed ID: 34695685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of Volatile Organic Compound Metabolites in Cigarette Smokers, Electronic Nicotine Device Users, Dual Users, and Nonusers of Tobacco.
    Keith RJ; Fetterman JL; Orimoloye OA; Dardari Z; Lorkiewicz PK; Hamburg NM; DeFilippis AP; Blaha MJ; Bhatnagar A
    Nicotine Tob Res; 2020 Feb; 22(2):264-272. PubMed ID: 30759242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differences in switching away from cigarettes and JUUL use characteristics among adult menthol and nonmenthol smokers who purchased the JUUL System.
    Goldenson NI; Augustson EM; Shiffman S
    Drug Alcohol Depend; 2022 Feb; 231():109238. PubMed ID: 34974269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of design characteristics and toxicant emissions from Vuse Solo and Alto electronic nicotine delivery systems.
    Talih S; Karaoghlanian N; Salman R; Fallah S; Helal A; El-Hage R; Saliba N; Breland A; Eissenberg T; Shihadeh A
    Tob Control; 2024 Sep; 33(5):676-679. PubMed ID: 37072168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of biomarkers of exposure among US adult smokers, users of electronic nicotine delivery systems, dual users and nonusers, 2018-2019.
    Holt NM; Shiffman S; Black RA; Goldenson NI; Sembower MA; Oldham MJ
    Sci Rep; 2023 May; 13(1):7297. PubMed ID: 37147399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "When I Don't Have a Cigarette It's Helpful, but It Really Don't Satisfy:" Qualitative Study of Electronic Nicotine Delivery Systems (ENDS) Use among Low-Income Smokers.
    Spears CA; Jones DM; Cottrell-Daniels C; Elahi H; Strosnider C; Luong J; Weaver SR; Pechacek TF
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular Outcomes among Combustible-Tobacco and Electronic Nicotine Delivery System (ENDS) Users in Waves 1 through 5 of the Population Assessment of Tobacco and Health (PATH) Study, 2013-2019.
    Mahoney MC; Rivard C; Kimmel HL; Hammad HT; Sharma E; Halenar MJ; Sargent J; Cummings KM; Niaura R; Goniewicz ML; Bansal-Travers M; Hatsukami D; Gaalema D; Fong G; Gravely S; Christensen CH; Haskins R; Silveira ML; Blanco C; Compton W; Stanton CA; Hyland A
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409819
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial.
    Cobb CO; Foulds J; Yen MS; Veldheer S; Lopez AA; Yingst JM; Bullen C; Kang L; Eissenberg T;
    Lancet Respir Med; 2021 Aug; 9(8):840-850. PubMed ID: 33857436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.